← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Gallagher grew fast through brokerage scale and acquisitions, but cash flow weakened and debt stepped up sharply.
The read at a glance✓ Audited against SEC data
- Growth — Revenue +20.7% to $13.94BOK
- Profitability — Net income +2.1% to $1.49BNote
- Cash — Operating cash flow -25.3%Watch
- Margins — Net margin -194 bps to 10.72%Watch
- Balance sheet — Debt +55869.6% to $12.87BWatch
- Insiders — 1 open-market buy / 14 sellsNote
Business
Arthur J. Gallagher is a global insurance brokerage, reinsurance brokerage, consulting, and third-party claims administration company. It places and services risk for clients, but says it does not assume underwriting risk on a net basis except for de minimis capital needed for captives and similar structures.
Where the revenue comes from
Fiscal 2025, as Arthur J. Gallagher & Co. reports it. History and quarterly detail are in the app.
- Brokerage$12.2B
- Risk Management$1.7B
- Corporate$1.0M
Leadership changes
From Arthur J. Gallagher & Co.'s own filings, the day they're filed.
- Sherry Barrat · Directors · departureeff. 2026-03-06
- Arthur J. Gallagher · Directors · departureeff. 2026-03-06
Latest filings
- 8-K · Company announcement2026-08-27
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-07-30
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-06-17
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Arthur J. Gallagher & Co., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.